cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Unity Biotechnology Inc
15 own
30 watching
Current Price
$4.48
$0.17
(3.94%)
logo-ubx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
62.88M
52-Week High
52-Week High
18.5
52-Week Low
52-Week Low
2.09
Average Volume
Average Volume
0.18M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization62.88M
icon52-Week High18.5
icon52-Week Low2.09
iconAverage Volume0.18M
iconDividend Yield--
iconP/E Ratio--
What does the Unity Biotechnology Inc do?
N/A
Read More
How much money does Unity Biotechnology Inc make?
News & Events about Unity Biotechnology Inc.
Globe Newswire
11days ago
SOUTH SAN FRANCISCO, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that from January 3, 2023, through January 17, 2023, the Compensation Committee...
PR Newswire
2 months ago
Thinking about buying stock in Atlas Corp, Unity Biotechnology, Abiomed, Tilray, or Pfizer? Thinking about buying stock in Atlas Corp, Unity Biotechnology, Abiomed, Tilray, or Pfizer? PR Newswire NEW YORK, Nov. 1, 2022 NEW YORK, Nov. 1, 2022 /PRNewswire/ --InvestorsObserverissues critical...
Globe Newswire
3 months ago
UBX common stock expected to begin trading on a split-adjusted basis on October20, 2022SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY or the Company) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt or reverse diseases of ...
Globe Newswire
5 months ago
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that members of its senior management team will participate in the following investor ...
Globe Newswire
5 months ago
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced the pricing of an upsized underwritten public offering of 64,285,714 shares of ...
Frequently Asked Questions
Frequently Asked Questions
What is Unity Biotechnology Inc share price today?
plus_minus_icon
Can Indians buy Unity Biotechnology Inc shares?
plus_minus_icon
How can I buy Unity Biotechnology Inc shares from India?
plus_minus_icon
Can Fractional shares of Unity Biotechnology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Unity Biotechnology Inc stocks?
plus_minus_icon
What is today’s traded volume of Unity Biotechnology Inc?
plus_minus_icon
What is today’s market capitalisation of Unity Biotechnology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Unity Biotechnology Inc?
plus_minus_icon
What percentage is Unity Biotechnology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Unity Biotechnology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.48
$0.17
(3.94%)
logo-ubx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00